5 Drug/Biotech Stocks With Promise To Sustain Bull Run In 2019

The performance of the drug/biotech space has been mixed so far this year. The Zacks Large Cap Pharmaceuticals industry (comprising some of the world’s biggest drugmakers) has gained 8.3% against the S&P 500 Composite’s decrease of 0.9%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.